Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Repurchase of Common Stock

Amneal Pharmaceuticals Inc Repurchase of Common Stock Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Repurchase of Common Stock from 2017 to 2017.
  • Amneal Pharmaceuticals Inc Repurchase of Common Stock for the quarter ending December 12, 2017 was $-2m
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Repurchase of Common Stock Data

12/2017$-2m